Read + Share
Amedeo Smart
Independent Medical Education
Bohm M, Xu R, Zhang Y, Varma S, et al. Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease. Aliment Pharmacol Ther 2020;52:669-681.PMID: 32656800
Email
LinkedIn
Facebook
Twitter
Privacy Policy